SCG2 and congenital bilateral aplasia of vas deferens from CFTR mutation: Moreover, increased levels of Scg2 have been associated with favorable clinical outcomes in certain cancers, such as kidney renal clear cell carcinoma, and in calcific aortic valve disease (CAVD) patients [27].